St. John's wort (hypericum perforatum): Practical considerations based on the evidence

Professional Psychology: Research and Practice

Volumn 32, Issue 3, 2001, Pages 329-332

  Rivas Vazquez, Rafael A ^a  

^a Neurologic Center of South Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035533219     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.32.3.329     Document Type: Review

References (33)

1. Barnett, J. E., & Neel, M. L. (2000). Must all psychologists study psychopharmacology? Professional Psychology: Research and Practice, 31, 619-627.
2. Beckman, S. E., Sommi, R. W., & Switzer, J. (2000). Consumer use of St. John's wort: A survey on effectiveness, safety and tolerability. Pharmacotherapy, 20, 568-574.
3. Breidenbach, T., Hoffman, M. W., Becker, T., Schlitt, H., & Klempnauer, J. (2000). Drug interaction of St. John's wort with ciclosporin [Correspondence]. The Lancet, 355, 1912.
4. Chatterjee, S. S., Bhattacharya, S. K., Wonnemann, M., Singer, A., & Muller, W. E. (1998). Hyperforin as a possible antidepressant component of hypericum extracts. Life Sciences, 63, 499-510.
5. Cott, J. M. (1997). In vitro receptor binding and enzyme inhibition by hypericum perforatum extract. Pharmacopsychiatry, 30(Suppl. 2), 108-112.
6. DeVane, C. L., & Nemeroff, C. B. (2000). 2000 guide to psychotropic drug interactions. Primary Psychiatry, 7(10), 40-68.
7. 2 extract on dopamine and serotonin release in the rat central nervous system. Pharmacopsychiatry, 33, 14-18.
8. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998). Trends in alternative medicine use in the United States, 1990-1997. JAMA, 280, 1569-1575.
9. Ernst, E. (1998). Harmless herbs? A review of the recent literature. American Journal of Medicine, 104, 170-178.
10. Ernst, E. (1999). Second thoughts about safety of St. John's wort. The Lancet, 354, 2014-2016.
11. Ernst, E., Rand, J. I., Barnes, J., & Stevinson, C. (1998). Adverse effects profile of the herbal antidepressant St. John's wort (hypericum perforatum L.). European Journal of Clinical Pharmacology, 54, 589-594.
12. Greub, B. L., & McNamara, J. R. (2000). Alternative therapies in psychological treatment: When is a consultation with a physician warranted? Professional Psychology: Research and Practice, 31, 58-63.
13. Kim, H. L., Streltzer, J., & Goebert, D. (1999). St. John's wort for depression: A meta-analysis of well-defined clinical trials. Journal of Nervous & Mental Disease, 187, 532-538.
14. Lal, S., & Iskandar, H. (2000). St. John's wort and schizophrenia [Letters]. Canadian Medical Association Journal, 163, 262-263.
15. Linde, K., & Mulrow, C. D. (2000). St. John's wort for depression. Retrieved from Cochrane Database of Systematic Reviews (CD-ROM, #CD000448).
16. Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., & Melchart, D. (1996). St. John's wort for depression: An overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 253-258.
17. Menkes, D. B. (2000). Use of hypericum as antidepressant: The herbalist will see you now [Letters]. British Medical Journal, 320, 1141.
18. Muller, W. E., Singer, A., Wonnemann, M., Hafner, U., Rolli, M., & Schafer, C. (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry, 31(Suppl. 1), 16-21.
19. Nathan, P. (1999). The experimental and clinical pharmacology of St. John's wort (hypericum perforatum). Molecular Psychiatry, 4, 333-338.
20. Nierenberg, A. A., Burt, T., Matthews, J., & Weiss, A. P. (1999). Mania associated with St. John's wort. Biological Psychiatry, 46, 1707-1708.
21. Philipp, M., Kohnen, R., & Hiller, K. O. (1999). Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks. British Medical Journal, 319, 1534-1539.
22. Philipp, M., Kohnen, R., & Hiller, K. O. (2000). Use of hypericum as antidepressant: Authors reply [Letters]. British Medical Journal, 320, 1141.
23. Pies, R. (2000). Adverse neuropsychiatric reactions to herbal and over-the-counter antidepressants. Journal of Clinical Psychiatry, 61, 815-820.
24. Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R., & Falloon, J. (2000). Indinavir concentrations and St. John's wort [Research letters]. The Lancet, 355, 547-548.
25. Ruschitzka, F., Meier, P. J., Turina, M., Lüscher, T. F., & Noll, G. (2000). Acute heart transplant rejection due to Saint John's wort [Research letters]. The Lancer, 355, 548-549.
26. Schrader, E. (2000). Equivalence of St. John's wort extract (ZE 117) and fluoxetine: A randomized, controlled study in mild-moderate depression. International Clinical Psychopharmacology, 15, 61-68.
27. Unützer, J., Klap, R., Sturm, R., Young, A. S., Marmon, T., Shatkin, J., & Wells, K. B. (2000). Mental disorders and the use of alternative medicine: Results from a national survey. American Journal of Psychiatry, 157, 1851-1857.
28. Vickers, A. (2000). Complementary medicine. British Medical Journal, 321, 683-686.
29. Wagner, P. J., Jester, D., LeClair, B., Taylor, A. T., Woodward, L., & Lambert, J. (1999). Taking the edge off: Why patients choose St. John's wort. Journal of Family Practice, 48, 615-619.
30. Wheatley, D. (1997). LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - A controlled 6-week clinical trial. Pharmacopsychiatry, 30(Suppl. 2), 77-80.
31. Williams, J. W., Mulrow, C., Chiquette, E., Noel, P. H., Aguilar, C., & Cornell, J. (2000). A systematic review of newer pharmacotherapies for depression in adults. Evidence report summary: Clinical guideline, Part 2. Annals of Internal Medicine, 132, 743-756.
32. Woelk, H. (2000). Comparison of St. John's wort and imipramine for treating depression: Randomised controlled trial. British Medical Journal, 321, 536-539.
33. Wong, A., Smith, M., & Boon, H. S. (1998). Herbal remedies in psychiatric practice. Archives of General Psychiatry, 55, 1033-1044.